在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Recombinant Human Rab proteins geranylgeranyltransferase component A 1 (CHM)

In Stock
  • 中文名稱:
    Recombinant Human Rab proteins geranylgeranyltransferase component A 1(CHM)
  • 貨號:
    CSB-EP005356HU
  • 規(guī)格:
    ¥1344
  • 圖片:
    • (Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
  • 其他:

產(chǎn)品詳情

  • 純度:
    Greater than 90% as determined by SDS-PAGE.
  • 基因名:
    CHM
  • Uniprot No.:
  • 別名:
    HM; Chm; Choroideraemia protein; Choroideremia; DXS540; FLJ38564; GGTA; HSD 32; MGC102710; Rab escort protein 1; Rab geranylgeranyltransferase component A; Rab proteins geranylgeranyltransferase component A 1; RAE1_HUMAN; REP 1; REP-1; REP1; TCD; TCD protein
  • 種屬:
    Homo sapiens (Human)
  • 蛋白長度:
    Full Length
  • 來源:
    E.coli
  • 分子量:
    77.5kDa
  • 表達(dá)區(qū)域:
    1-653aa
  • 氨基酸序列
    MADTLPSEFDVIVIGTGLPESIIAAACSRSGRRVLHVDSRSYYGGNWASFSFSGLLSWLKEYQENSDIVSDSPVWQDQILENEEAIALSRKDKTIQHVEVFCYASQDLHEDVEEAGALQKNHALVTSANSTEAADSAFLPTEDESLSTMSCEMLTEQTPSSDPENALEVNGAEVTGEKENHCDDKTCVPSTSAEDMSENVPIAEDTTEQPKKNRITYSQIIKEGRRFNIDLVSKLLYSRGLLIDLLIKSNVSRYAEFKNITRILAFREGRVEQVPCSRADVFNSKQLTMVEKRMLMKFLTFCMEYEKYPDEYKGYEEITFYEYLKTQKLTPNLQYIVMHSIAMTSETASSTIDGLKATKNFLHCLGRYGNTPFLFPLYGQGELPQCFCRMCAVFGGIYCLRHSVQCLVVDKESRKCKAIIDQFGQRIISEHFLVEDSYFPENMCSRVQYRQISRAVLITDRSVLKTDSDQQISILTVPAEEPGTFAVRVIELCSSTMTCMKGTYLVHLTCTSSKTAREDLESVVQKLFVPYTEMEIENEQVEKPRILWALYFNMRDSSDISRSCYNDLPSNVYVCSGPDCGLGNDNAVKQAETLFQEICPNEDFCPPPPNPEDIILDGDSLQPEASESSAIPEANSETFKESTNLGNLEESSE
    Note: The complete sequence may include tag sequence, target protein sequence, linker sequence and extra sequence that is translated with the protein sequence for the purpose(s) of secretion, stability, solubility, etc.
    If the exact amino acid sequence of this recombinant protein is critical to your application, please explicitly request the full and complete sequence of this protein before ordering.
  • 蛋白標(biāo)簽:
    N-terminal 6xHis-tagged
  • 產(chǎn)品提供形式:
    Liquid or Lyophilized powder
    Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
  • 緩沖液:
    If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol.
    Note: If you have any special requirement for the glycerol content, please remark when you place the order.
    If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose.
  • 儲存條件:
    Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
  • 保質(zhì)期:
    The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
    Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
  • 貨期:
    3-7 business days
  • 注意事項(xiàng):
    Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
  • Datasheet & COA:
    Please contact us to get it.

產(chǎn)品評價(jià)

靶點(diǎn)詳情

  • 功能:
    Substrate-binding subunit of the Rab geranylgeranyltransferase (GGTase) complex. Binds unprenylated Rab proteins and presents the substrate peptide to the catalytic component B composed of RABGGTA and RABGGTB, and remains bound to it after the geranylgeranyl transfer reaction. The component A is thought to be regenerated by transferring its prenylated Rab back to the donor membrane. Besides, a pre-formed complex consisting of CHM and the Rab GGTase dimer (RGGT or component B) can bind to and prenylate Rab proteins; this alternative pathway is proposed to be the predominant pathway for Rab protein geranylgeranylation.
  • 基因功能參考文獻(xiàn):
    1. Molecular genetics characterization and homology modeling of the CHM gene mutation: A study on its association with choroideremia. PMID: 29555028
    2. our results suggest that c.280delA (p.Thr94LeufsTer32) in CHM was a pathogenic mutation in the present choroideremia family as determined by captured exome sequencing. PMID: 29620233
    3. REP1 plays a crucial role in regulating mTOR signaling and its downstream pathways, as well as autophagy and macropinocytosis. PMID: 28846638
    4. All coding exons and flanking intronic regions of the CHM gene revealed a novel small deletion at a splice site (c.184_189+3delTACCAGGTA) in one patient and a deletion of the entire exon 9 in the other. PMID: 28643494
    5. These findings suggest that the CHM promoter region should be examined in patients with CHM who lack coding sequence mutations, and reveals, for the first time, features of the gene's regulation PMID: 28271586
    6. We report here the characterization of the third pathogenic missense CHM variant, p.Leu457Pro. Clinically, the associated phenotype is indistinguishable from that of loss-of-function mutations. PMID: 28911202
    7. Retinal dystrophy and SDD were detected in our female CHM carriers, and fundus patterns PMID: 28752371
    8. Overexpression of REP1 in BEAS-2B cells enhanced cell growth and anchorage-independent colony formation with little increase in EGFR level and STAT3 activation. PMID: 28230863
    9. we demonstrated that REP1 blocked the nuclear trans-localization of FOXO3 through physically interacting with FOXO3, thereby suppressing FOXO3-mediated apoptosis. Importantly, the inhibition of REP1 combined with 5-FU treatment could lead to significant retarded tumor growth in a xenograft tumor model of human cancer cells PMID: 28055019
    10. Our results showed CNV within the Rep-1 gene could be an important contributor in Chinese Choroideremia patients. PMID: 28774736
    11. In Choroideremia(Y42X/y) fibroblasts, there was a recovery of prenylation activity following treatment with either PTC124 (42 +/- 5%) or PTC-414 (36 +/- 11%), although an increase in REP1 protein was not detected in these cells, in contrast to the zebrafish model. PMID: 27329764
    12. We describe the causative mutations in a large cohort of patients who also were examined clinically and explore potential genotype-phenotype correlations. By so doing, we further aimed to make inferences regarding the importance of particular regions of the CHM gene with respect to mutagenesis and to infer the importance of particular regions of the REP1 protein essential for normal function. PMID: 27820636
    13. Six previously reported and five novel CHM mutations were detected in 11 Australian families clinically diagnosed with choroideremia. PMID: 25912515
    14. The family segregated a REP1 mutation, suggesting choroideremia (CHM). PMID: 26720468
    15. We report a novel CHM mutation, c.1475_1476insCA, identified by whole-exome sequencing in a family with X-linked CHM initially diagnosed as retinitis pigmentosa. PMID: 26216097
    16. Sanger sequencing confirmed the mutations in CHM, including four novel (c.558_559delTT, c.964G>T, c.966delA, c.1166+2T>G) and two known (c.7031G>A and c.1584_1587delTGTT) mutations. PMID: 24913019
    17. the clinical and molecular findings of an Italian family with a new mutation in the choroideremia (CHM) gene, are reported. PMID: 24672218
    18. While likely an uncommon event, duplication within the CHM gene could be considered as an explanation for CHM cases in which no mutation is found by sequence analysis. PMID: 23273018
    19. Data found pathogenic DNA variants in the genes RP1, USH2A, CNGB3, NMNAT1, CHM, and ABCA4, responsible for retinitis pigmentosa, Usher syndrome, achromatopsia, Leber congenital amaurosis, choroideremia, or recessive Stargardt/cone-rod dystrophy cases. PMID: 23940504
    20. These findings demonstrate a novel CHM mutation that emphasizes severe posterior pole carrier phenotypes, age-related changes, and early choroideremia disease. PMID: 22965595
    21. In Mainland Chinese families, the central visual acuity of male patients with CHM can be affected at an early age (second decade), whereas female CHM carriers may manifest signs and symptoms at a later age (>/= 45 years). PMID: 22355242
    22. We identified a novel REP1 missense variant (c.1520A>G; p.H507R) associated with CHM that prevents REP1-Rab geranylgeranyl transferase interaction. PMID: 21905166
    23. A novel mutation was detected in CHM gene in family 1. Another mutation within exon 14 of CHM was identified in family 2. The mutations caused night blindness, chorioretinal atrophy, and bareness of the sclera. PMID: 22025891
    24. an interaction between a transmembrane receptor and RGGTA PMID: 21990357
    25. It is suggested that expression levels of alternative transcripts of the CHM gene could be used as a molecular marker system to identify human cancers. PMID: 21939745
    26. Intracellular vesicle transport, lysosomal acidification and rates of proteolytic degradation were studied in Choroideremia patients carrying 10 different loss-of-function REP1 mutations. PMID: 20027300
    27. In vitro assembly and purification of the stoichiometric ternary complex of RabGGTase with REP-1 stabilized by a hydrolysis-resistant phosphoisoprenoid analog--farnesyl phosphonyl(methyl)phoshonate. PMID: 11886217
    28. We report for the first time the identification of an intronic mutation remote from the exon-intron junctions that creates a strong acceptor splice site and leads to the inclusion of a cryptic exon into the CHM mRNA. PMID: 12827496
    29. Frameshift mutation of REP-1 gene is associated with choroideremia PMID: 14566650
    30. The C terminus of the REP-1 molecule functions as a mobile lid covering a conserved hydrophobic patch on the surface of REP-1 that in the complex coordinates the C terminus of Rab proteins. PMID: 15186776
    31. Chm is essential for diploid trophoblast development and plays a role in the vascularization in placenta and yolk sac PMID: 15242790
    32. DNA analysis revealed that the patient was heterozygous for a previously undescribed substitution mutation at the 3'-splice site of intron 6 of the CHM gene (850-1 G to C), confirmed by mRNA analysis with reverse transcriptase polymerase chain reaction. PMID: 15465555
    33. The authors found a 402delT and a 555-556delAG mutation in the CHM gene, one of which (402delT) is a novel mutation. PMID: 15579993
    34. Normal electroretinogram is preserved in patients with nonsense mutation in exon 6 of the choroideremia CHM gene. PMID: 16087855
    35. The results represent in vivo evidence in humans for retinal remodeling and provide a marker for the earliest stage of this response to genetic retinal disease. PMID: 16936131
    36. Deletion of the CHM gene causes severe choroideremia. Results of serial ERGs and fundus examinations documented progression first of rod and then of cone disease. PMID: 17698759
    37. This is the first study reporting mutations in the CHM gene in Chinese families. Mutational analysis was performed at the DNA, mRNA and protein levels. Five truncating mutations were found, and two of these were novel. PMID: 18087237
    38. Novel type of mutation did not result in a truncated or absent protein. Rather, these patients lost different parts of the REP-1 mRNA in-frame that in all the cases encode a conserved protein domain implicated in the interaction with Rab proteins. PMID: 18385043
    39. Fundus autofluorescence patterin is specific to syndromic choroideremia carriers and thus will help to identify and differentiate between carriers of other X-linked recessive carrier states such as in X-linked retinitis pigmentosa. PMID: 18487380
    40. When over-expressed in cells, REP wild-type and mutants are unable to form stable cytosolic complexes with endogenous unprenylated Rabs. PMID: 18532927
    41. A novel (967-970+2)delAAAGGT mutation existed in the CHM gene of a Japanese family with choroideremia. PMID: 18773267
    42. All 6 carriers of CHM showed a characteristic FAF pattern that can guide mutation analysis. PMID: 19376587
    43. Genomic DNA from the living brother revealed a transition mutation, C to T, in exon 6 which resulted in a stop codon and was predicted to truncate the protein product. PMID: 19422966
    44. report pathogenic mutations: a novel missense mutation, L550P; a truncation c.1542T>A, STOP; and two deletions (c.525_526delAG and c.1646delC) in the CHM gene and their phenotypic effect in choroideremia PMID: 19427510
    45. The typical mottled irregularity in fundus autofluorescence is a valuable diagnostic criterion that facilitates specific genetic testing. PMID: 19597113
    46. CHM gene molecular analysis and X-chromosome inactivation pattern determination in two families with choroideremia. PMID: 19764077

    顯示更多

    收起更多

  • 相關(guān)疾病:
    Choroideremia (CHM)
  • 亞細(xì)胞定位:
    Cytoplasm, cytosol.
  • 蛋白家族:
    Rab GDI family
  • 數(shù)據(jù)庫鏈接:

    HGNC: 1940

    OMIM: 300390

    KEGG: hsa:1121

    STRING: 9606.ENSP00000350386

    UniGene: Hs.496449



主站蜘蛛池模板: 男女啪啪做爰高潮无遮挡| 国产丝袜足j在线视频播放| 亚洲午夜福利av一区二区无码| 精品无码久久久久久久久| 四虎永久在线精品免费视频观看| 女性自慰网站免费观看w| 亚洲欧美综合精品久久成人网| 国产精品无码久久四虎| 精品 在线 视频 亚洲| 日韩精品一区二区午夜成人版| 狠狠综合久久久久尤物丿| 国产精品免费观看久久| 国产精品美脚玉足脚交欧美| 好男人资源在线www免费| 亚洲日韩看片无码超清| 久青草久青草视频在线观看| 国产无遮挡又黄又爽免费视频| 国产午夜福利在线观看视频| 欧美性xxxx狂欢老少配| 在线观看片免费人成视频播放| 免费毛片手机在线播放| 玩弄放荡人妻少妇系列| 97人妻天天摸天天爽天天| 2018国产大陆天天弄| 18禁亚洲深夜福利人口| 中文字幕无码精品亚洲资源网| 99久久99久久免费精品蜜桃| 久久久日韩精品一区二区| 国产动作大片中文字幕| 国产在线高清亚洲精品二区| 欧美欧洲成本大片免费| 无码h肉动漫在线观看| 日本少妇被黑人xxxxx| 国产福利高颜值在线观看 | 少妇荡乳情欲办公室456视频| 日韩中文高清在线专区| 亚洲欧洲自拍拍偷综合| 超薄肉色丝袜一区二区| 成人免费777777被爆出| 亚洲va久久久噜噜噜久久4399| 男女做爽爽爽视频免费软件|